Enovis Corporation Logo

Enovis Corporation

0I1B.L

(0.0)
Stock Price

42,66 USD

0% ROA

-1.42% ROE

0x PER

Market Cap.

0,00 USD

0% DER

0% Yield

-2.86% NPM

Enovis Corporation Stock Analysis

Enovis Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Enovis Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Enovis Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Enovis Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Enovis Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Enovis Corporation Revenue
Year Revenue Growth
2012 3.913.856.000
2013 4.207.209.000 6.97%
2014 4.624.476.000 9.02%
2015 3.434.352.000 -34.65%
2016 3.185.753.000 -7.8%
2017 1.937.282.000 -64.44%
2018 2.193.083.000 11.66%
2019 3.327.458.000 34.09%
2020 1.120.700.000 -196.91%
2021 1.426.188.000 21.42%
2022 1.563.101.000 8.76%
2023 1.670.096.000 6.41%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Enovis Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2012 19.400.000
2013 27.400.000 29.2%
2014 43.000.000 36.28%
2015 38.000.000 -13.16%
2016 39.300.000 3.31%
2017 32.799.999 -19.82%
2018 34.200.000 4.09%
2019 61.800.000 44.66%
2020 34.268.000 -80.34%
2021 49.094.000 30.2%
2022 60.827.000 19.29%
2023 79.604.000 23.59%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Enovis Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 785.133.000
2013 774.016.000 -1.44%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Enovis Corporation EBITDA
Year EBITDA Growth
2012 438.089.000
2013 552.152.000 20.66%
2014 631.698.000 12.59%
2015 462.083.000 -36.71%
2016 427.258.000 -8.15%
2017 305.834.000 -39.7%
2018 330.290.000 7.4%
2019 570.185.000 42.07%
2020 206.228.000 -176.48%
2021 250.211.000 17.58%
2022 205.178.000 -21.95%
2023 203.176.000 -0.99%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Enovis Corporation Gross Profit
Year Gross Profit Growth
2012 1.173.725.000
2013 1.306.222.000 10.14%
2014 1.478.845.000 11.67%
2015 1.071.686.000 -37.99%
2016 992.382.000 -7.99%
2017 671.579.000 -47.77%
2018 729.376.000 7.92%
2019 1.409.508.000 48.25%
2020 610.240.000 -130.98%
2021 793.633.000 23.11%
2022 883.885.000 10.21%
2023 971.872.000 9.05%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Enovis Corporation Net Profit
Year Net Profit Growth
2012 -83.353.000
2013 154.492.000 153.95%
2014 370.185.000 58.27%
2015 157.511.000 -135.02%
2016 137.672.000 -14.41%
2017 27.659.000 -397.75%
2018 107.595.000 74.29%
2019 8.363.000 -1186.56%
2020 -75.119.000 111.13%
2021 -103.305.000 27.28%
2022 -38.756.000 -166.55%
2023 -77.964.000 50.29%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Enovis Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 -3
2013 5 150%
2014 9 55.56%
2015 4 -200%
2016 3 0%
2017 1 0%
2018 3 100%
2019 0 0%
2020 -2 100%
2021 -2 50%
2022 -1 0%
2023 -1 100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Enovis Corporation Free Cashflow
Year Free Cashflow Growth
2012 90.833.000
2013 290.687.000 68.75%
2014 301.300.000 3.52%
2015 233.936.000 -28.8%
2016 183.723.000 -27.33%
2017 150.005.000 -22.48%
2018 156.721.000 4.29%
2019 5.546.000 -2725.84%
2020 187.150.000 97.04%
2021 251.862.000 25.69%
2022 -161.311.000 256.13%
2023 3.982.000 4151%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Enovis Corporation Operating Cashflow
Year Operating Cashflow Growth
2012 174.020.000
2013 362.169.000 51.95%
2014 385.758.000 6.11%
2015 303.813.000 -26.97%
2016 246.974.000 -23.01%
2017 218.770.000 -12.89%
2018 226.367.000 3.36%
2019 130.948.000 -72.87%
2020 301.935.000 56.63%
2021 356.099.000 15.21%
2022 -55.861.000 737.47%
2023 31.013.000 280.12%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Enovis Corporation Capital Expenditure
Year Capital Expenditure Growth
2012 83.187.000
2013 71.482.000 -16.37%
2014 84.458.000 15.36%
2015 69.877.000 -20.87%
2016 63.251.000 -10.48%
2017 68.765.000 8.02%
2018 69.646.000 1.26%
2019 125.402.000 44.46%
2020 114.785.000 -9.25%
2021 104.237.000 -10.12%
2022 105.450.000 1.15%
2023 27.031.000 -290.11%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Enovis Corporation Equity
Year Equity Growth
2012 2.156.286.000
2013 2.741.123.000 21.34%
2014 3.352.444.000 18.24%
2015 3.256.556.000 -2.94%
2016 3.093.344.000 -5.28%
2017 3.727.264.000 17.01%
2018 3.476.946.000 -7.2%
2019 3.489.628.000 0.36%
2020 3.587.873.999 2.74%
2021 4.661.433.000 23.03%
2022 3.449.801.000 -35.12%
2023 3.441.732.000 -0.23%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Enovis Corporation Assets
Year Assets Growth
2012 6.148.287.000
2013 6.601.184.000 6.86%
2014 7.211.517.000 8.46%
2015 6.732.919.000 -7.11%
2016 6.338.440.000 -6.22%
2017 6.709.697.000 5.53%
2018 6.615.958.000 -1.42%
2019 7.386.832.000 10.44%
2020 7.351.549.000 -0.48%
2021 8.515.912.000 13.67%
2022 4.273.247.999 -99.28%
2023 4.400.917.000 2.9%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Enovis Corporation Liabilities
Year Liabilities Growth
2012 3.992.001.000
2013 3.860.061.000 -3.42%
2014 3.859.073.000 -0.03%
2015 3.476.363.000 -11.01%
2016 3.245.096.000 -7.13%
2017 2.982.433.000 -8.81%
2018 3.139.012.000 4.99%
2019 3.897.204.000 19.45%
2020 3.763.675.000 -3.55%
2021 3.854.479.000 2.36%
2022 823.447.000 -368.09%
2023 959.185.000 14.15%

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Enovis Corporation Dividends
Year Dividends Growth

Enovis Corporation Profile

About Enovis Corporation

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

CEO
Mr. Mitchell P. Rales
Employee
16.200
Address
2711 Centerville Road
Wilmington, 19808

Enovis Corporation Executives & BODs

Enovis Corporation Executives & BODs
# Name Age

Enovis Corporation Competitors